The aim of this study was to investigate whether 3′-deoxy-3′-18F-fluorothymidine (18F-
FLT) can monitor the early response of tumor cell proliferation to charged particle irradiation …

3′-Deoxy-3′-18F-fluorothymidine (18F-FLT) has been suggested as a new PET tracer for
imaging tumor proliferation. We investigated the use of 18F-FLT to monitor the response of …

Noninvasive monitoring of tumor therapy response helps in developing personalized
treatment strategies. Here, we performed sequential PET and diffusion-weighted MRI to …

3′-Deoxy-3′-18F-fluorothymidine (18F-FLT) is a PET imaging agent that shows promise
for studying cellular proliferation in human cancers. FLT is a nucleoside analog that enters …

Abstract Purpose 3′-Deoxy-3′-[18 F] fluorothymidine (FLT) is a promising new
radiopharmaceutical for imaging cell proliferation. We evaluated whether FLT PET can be …

The radiotracer 3′-deoxy-3′-18F-fluorothymidine (18F-FLT) is commonly used to measure
cell proliferation in vivo. As a marker of cell proliferation, 18F-FLT is expected to be …

Objective The aim of our study was to explore the value of 3′-deoxy-3′-[18 F]
fluorothymidine (18 F-FLT) and 18 F-FLT PET in monitoring the early biologic response of …

Purpose We recently reported that high thymidine phosphorylase (TP) expression is
accompanied by low tumor thymidine concentration and high 3′-deoxy-3′-[18 F] …

3′-Deoxy-3′-18F-fluorothymidine (18F-FLT), a partially metabolized thymidine analog,
has been used in preclinical and clinical settings for the diagnostic evaluation and …

Background 18 F-FLT is a novel PET radiotracer which has demonstrated a strong potential
utility for imaging cellular proliferation in human tumors in vivo. To facilitate future regulatory …